Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S.

Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...

Paycom Software (PAYC) shares advanced as KeyBanc upgraded the stock and raised the price target on optimism about sales, ...

The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...

Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...

The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...

Dexcom (Nadsaq:DXCM) announced today that it received a warning letter from the FDA following inspections of two company ...

The investor has been working behind the scenes at the tech-services firm and isn't currently planning to nominate directors. The regulator said Robinhood had violated "numerous" rules, including ...

EST DexCom (DXCM) falls 7% to $71.99 after receiving warning letter from FDADiscover the Best Stocks and Maximize Your Portfolio: See ...

Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...

In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...